Form 4: Revelation Biosciences Director Acquires Additional Shares

George F. Tidmarsh, a director at Revelation Biosciences, acquired additional shares of common stock through a trust and a restricted stock grant.

Summary

• On February 11, 2025, George F. Tidmarsh, a director of Revelation Biosciences, acquired 181 shares of common stock at a price of $3.87 per share.
• These shares were acquired through a restricted stock grant under the 2021 Equity Incentive Plan, which vests 100% on the date of grant.
• Tidmarsh also holds 87 shares of common stock indirectly through the George Francis Tidmarsh 2021 Irrevocable Trust.
• Following the reported transactions, Tidmarsh beneficially owns 268 shares indirectly through the trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of share acquisition by a director. It doesn't inherently indicate positive or negative sentiment, but rather provides information for investors to interpret.

Positives

• The acquisition of shares by a director may signal confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if interpreted as a sign of confidence from a company director.

Key Dates

Keywords

Revelation Biosciences, REVB, George Tidmarsh, Director, Share Acquisition, Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Grant, Equity Incentive Plan